DZ Bank restated their buy rating on shares of Capital Stage (ETR:CAP) in a research report released on Wednesday.

A number of other brokerages have also weighed in on CAP. Baader Bank set a €7.80 ($9.29) price objective on Capital Stage and gave the stock a buy rating in a report on Tuesday, December 5th. Warburg Research set a €8.50 ($10.12) target price on Capital Stage and gave the company a buy rating in a report on Friday, November 3rd. Five investment analysts have rated the stock with a buy rating, The stock has a consensus rating of Buy and an average price target of €7.99 ($9.51).

Shares of Capital Stage (CAP) traded up €0.21 ($0.25) during mid-day trading on Wednesday, reaching €6.97 ($8.30). The company had a trading volume of 439,946 shares, compared to its average volume of 183,105. Capital Stage has a 52-week low of €5.85 ($6.96) and a 52-week high of €6.92 ($8.24). The firm has a market capitalization of $881.09 and a price-to-earnings ratio of 30.30.

COPYRIGHT VIOLATION NOTICE: “DZ Bank Reaffirms Buy Rating for Capital Stage (CAP)” was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The legal version of this story can be read at https://www.watchlistnews.com/dz-bank-reaffirms-buy-rating-for-capital-stage-cap/1812682.html.

About Capital Stage

Capital Stage AG is a principal investment firm specializing in acquisition and operation of solar and onshore-wind energy and parks. It does not focus on investing in Greenfield projects from scratch or take significant development or construction risk. It invests in Germany, France, and Italy. The firm typically invests up to ??5 million ($6.62 million) and ??20 million ($26.50 million) in "key ready" parks/plants.

Analyst Recommendations for Capital Stage (ETR:CAP)

Receive News & Ratings for Capital Stage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Capital Stage and related companies with MarketBeat.com's FREE daily email newsletter.